Mosseri Marlio Charles's Form 4 filing
Nuvectis Pharma, Inc. (NVCT) · filed Oct 29, 2025
- Accession no.
- 0001104659-25-103522
- Filed
- Oct 29, 2025
- Trade date
- Oct 23-27, 2025
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $957.1K. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mosseri Marlio CharlesCIK 0001806384 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 23, 2025 | Common Stock | PPurchaseAcquired | +46,900 | $6.06 | +$284,214 | 3,028,706 | Indirect | |
| Oct 24, 2025 | Common Stock | PPurchaseAcquired | +35,034 | $6.15 | +$215,459.1 | 3,063,740 | Indirect | |
| Oct 27, 2025 | Common Stock | PPurchaseAcquired | +72,836 | $6.28 | +$457,410.08 | 3,136,576 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.